The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | C | Cardiovascular system | |
| 2 | C02 | Antihypertensives | |
| 3 | C02C | Antiadrenergic agents, peripherally acting | |
| 4 | C02CC | Guanidine derivatives |
| Code | Title | |
|---|---|---|
| C02CC01 | Betanidine | |
| C02CC02 | Guanethidine | |
| C02CC03 | Guanoxan | |
| C02CC04 | Debrisoquine | |
| C02CC05 | Guanoclor | |
| C02CC06 | Guanazodine | |
| C02CC07 | Guanoxabenz |
| Active Ingredient | Description | |
|---|---|---|
| Betanidine |
Betanidine is a post-ganglionic adrenergic neurone-blocking agent which exerts a marked postural hypotensive effect. |
|
| Guanethidine |
Guanethidine is a antihypertensive drug. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues. It is taken up by norepinephrine transporters. It becomes concentrated in norepinephrine transmitter vesicles, replacing norepinephrine in these vesicles. |
